Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology-Reference-Cited by-同舟云学术

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Published:2013-06 Issue:6 Volume:137 Page:828-860
ISSN:0003-9985
Container-title:Archives of Pathology & Laboratory Medicine
language:en
Short-container-title:Archives of Pathology & Laboratory Medicine

Author:

Lindeman Neal I.,Cagle Philip T.,Beasley Mary Beth,Chitale Dhananjay Arun,Dacic Sanja,Giaccone Giuseppe,Jenkins Robert Brian,Kwiatkowski David J.,Saldivar Juan-Sebastian,Squire Jeremy,Thunnissen Erik,Ladanyi Marc

Publisher

Archives of Pathology and Laboratory Medicine

Subject

Medical Laboratory Technology,General Medicine,Pathology and Forensic Medicine

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of potential reference measurement procedure and reference materials for EML4-ALK fusion variants measurement;2024-09-10

2. Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer;Cancers;2024-06-26

3. The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database;Lung Cancer;2024-05

4. EGFR exon 18 delE709_T710insD mutated stage IV non-small cell lung cancer treated with osimertinib: a case report;Anti-Cancer Drugs;2024-03-15

5. For Squamous Cancers, the Streetlamps Shine on Occasional Keys, Most Baskets Are Empty, and the Umbrellas Cannot Keep Us Dry: A Call for New Models in Precision Oncology;Journal of Clinical Oncology;2024-02-10